Novartis vs UnitedHealth Group

Novartis (NVS), health care, and UnitedHealth Group (UNH), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

UnitedHealth Group is worth $357.1B on the stock market and Novartis $301.5B: UnitedHealth Group is valued at 18% more. Novartis trades at 30.5 times earnings and UnitedHealth Group at 22.7; operating margins in their latest fiscal years were 32.4% and 4.24%. Over the past year Novartis's share price has moved +25.1% and UnitedHealth Group's +31.4%.

Key facts

Novartis market value
$301.5B
UnitedHealth Group market value
$357.1B
Novartis P/E
30.5
UnitedHealth Group P/E
22.7
Novartis revenue
$54.5BFY to 2025-12-31
UnitedHealth Group revenue
$447.6BFY to 2025-12-31
Superinvestors holding both
7

Market values as of .

Novartis vs UnitedHealth Group: every measure side by side
Measure Novartis UnitedHealth Group
SectorHealth CareHealth Care
Country Switzerland United States
Fiscal year ends2025-12-312025-12-31
Size
Market cap$301.5Blower$357.1Bhigher
Revenue$54.5Blower$447.6Bhigher
Earnings$14Bhigher$12.1Blower
Employees75,267lower390,000higher
Total assets$110.9Blower$309.6Bhigher
Valuation
P/E30.5higher22.7lower
P/S5.5higher0.8lower
P/B—3.6
Dividend yield—2.20%
Profitability
Operating margin32.4%higher4.24%lower
Balance sheet
Net assets$46.1Blower$100.1Bhigher
Total liabilities$64.4Blower$207.9Bhigher
Total debt$28.7Blower$77.7Bhigher
Cash on hand$11.4Blower$24.4Bhigher
Price change
Today-0.35%higher-3.27%lower
1 year+25.1%lower+31.4%higher

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Percentages are each holding's share of that investor's reported portfolio (under "Both": Novartis / UnitedHealth Group). Who owns NVS · Who owns UNH

Further comparisons

Learn

Questions and answers

Which is bigger, Novartis or UnitedHealth Group?

By market value, UnitedHealth Group is the larger: $357.1B against $301.5B for Novartis. By revenue in its latest fiscal year, UnitedHealth Group is the larger: $447.6B against $54.5B for Novartis.

Which has the higher P/E ratio?

Novartis: 30.5, against 22.7 for UnitedHealth Group. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

Which has the higher operating margin?

Novartis: 32.4%, against 4.24% for UnitedHealth Group. Operating margin is operating income as a share of revenue in the latest fiscal year.

Which has more debt?

UnitedHealth Group: $77.7B, against $28.7B for Novartis. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

Which superinvestors own both Novartis and UnitedHealth Group?

In their latest 13F filings, Tweedy, Browne team, Ken Fisher, Andrew Spokes, Charles Brandes (founder), Jeremy Grantham (co-founder), Dodge & Cox team and Rajiv Jain hold both.

Cite this page

Funkfolio, “Novartis vs UnitedHealth Group”, data as of 17 November 2026. https://funkfolio.com/compare/nvs-vs-unh

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.